1. Home
  2. FOLD vs FLO Comparison

FOLD vs FLO Comparison

Compare FOLD & FLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • FLO
  • Stock Information
  • Founded
  • FOLD 2002
  • FLO 1919
  • Country
  • FOLD United States
  • FLO United States
  • Employees
  • FOLD N/A
  • FLO N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • FLO Packaged Foods
  • Sector
  • FOLD Health Care
  • FLO Consumer Staples
  • Exchange
  • FOLD Nasdaq
  • FLO Nasdaq
  • Market Cap
  • FOLD 2.9B
  • FLO 3.4B
  • IPO Year
  • FOLD 2007
  • FLO N/A
  • Fundamental
  • Price
  • FOLD $7.58
  • FLO $15.04
  • Analyst Decision
  • FOLD Strong Buy
  • FLO Hold
  • Analyst Count
  • FOLD 10
  • FLO 4
  • Target Price
  • FOLD $26.89
  • FLO $16.50
  • AVG Volume (30 Days)
  • FOLD 3.8M
  • FLO 2.9M
  • Earning Date
  • FOLD 07-31-2025
  • FLO 08-15-2025
  • Dividend Yield
  • FOLD N/A
  • FLO 6.58%
  • EPS Growth
  • FOLD N/A
  • FLO 71.08
  • EPS
  • FOLD N/A
  • FLO 1.04
  • Revenue
  • FOLD $571,160,000.00
  • FLO $5,098,751,000.00
  • Revenue This Year
  • FOLD $20.98
  • FLO $4.36
  • Revenue Next Year
  • FOLD $20.74
  • FLO $0.17
  • P/E Ratio
  • FOLD N/A
  • FLO $14.46
  • Revenue Growth
  • FOLD 25.35
  • FLO N/A
  • 52 Week Low
  • FOLD $5.51
  • FLO $14.74
  • 52 Week High
  • FOLD $12.65
  • FLO $23.87
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 69.88
  • FLO 39.16
  • Support Level
  • FOLD $7.40
  • FLO $14.74
  • Resistance Level
  • FOLD $7.80
  • FLO $15.98
  • Average True Range (ATR)
  • FOLD 0.22
  • FLO 0.40
  • MACD
  • FOLD 0.01
  • FLO -0.12
  • Stochastic Oscillator
  • FOLD 87.61
  • FLO 13.98

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

About FLO Flowers Foods Inc.

Flowers Foods Inc is an American company producing bakery food for retail and foodservice across the United States. The product portfolio includes fresh breads, buns, rolls, snack cakes, and tortillas. The company distributes to supermarkets, convenience stores, and restaurants. The key brands are Nature's Own, Wonder, Tastykake, Canyon Bakehouse, DKB.

Share on Social Networks: